Investment Opportunities in the US Cell Line Development Market with 13.3% CAGR
The United States represents the largest share of the North American cell line development landscape, driven by its strong biopharmaceutical ecosystem, extensive research infrastructure, and significant investments in biotechnology innovation. The country is home to numerous pharmaceutical and biotechnology companies engaged in the development of biologics, biosimilars, cell therapies, and gene...
0 Комментарии 0 Поделились 5 Просмотры 0 предпросмотр